Insulin-like growth factor binding protein 3 in inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 50, Issue 4, 2005, Pages 780-784

  Kirman, Irena ^a   Whelan, Richard Larry ^a   Jain, Suvinit ^a   Nielsen, Sara Elsøe ^b   Seidelin, Jakob Benedict ^b   Nielsen, Ole Haagen ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Crohn's disease; Insulin growth factor; Insulin growth factor binding protein 3; Ulcerative colitis

Indexed keywords

GELATINASE B; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; DISEASE ACTIVITY; DNA CLEAVAGE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REMISSION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; ZYMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OSMOLAR CONCENTRATION; PEPTIDE HYDROLASES; SEVERITY OF ILLNESS INDEX;

EID: 17644393137     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2573-1     Document Type: Article

References (24)

1. Serafini EP, Kirk AP, Chambers TJ: Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut 22:648-652, 1981
2. Noffsinger AE, Miller MA, Cusi MV, et al.: The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis. Cancer 78:2307-2312, 1996
3. Shinozaki M, Watanabe T, Kubota Y, et al.: High proliferative activity is associated with dysplasia in ulcerative colitis. Dis Colon Rectum 43(Suppl 10):S34-S39, 2000
4. Di Sabatino A, Ciccocioppo R, Luinetti O, et al.: Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum 46:1498-1507, 2003
5. Yukawa M, Iizuka M, Horie Y, et al.: Systemic and local evidence of increased Fas-mediated apoptosis in ulcerative colitis. Int J Colorectal Dis 17:70-76, 2002
6. Strater J, Wellisch I, Riedl S, et al.: Related CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 113:160-167, 1997
7. Akobeng AI, Clayton PE, Miller V, et al.: Low serum concentrations of insulin-like growth factor-I in children with active Crohn disease: effect of enteral nutritional support and glutamine supplementation. Scand J Gastroenterol 37:1422-1427, 2002
8. Gronbek H, Thogersen T, Frystyk J, et al.: Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment. Am J Gastroenterol 97:673-678, 2002
9. Katsanos KH, Tsatsoulis A, Christodoulou D, et al.: Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease. Growth Horm IGF Res 11:364-367, 2001
10. Lee KW, Liu B, Ma L, et al.: Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 279:469-476, 2004
11. Schedlich LJ, Le Page SL, Firth SM, et al.: Nuclear import of insulin-like growth factor-binding protein-3 and 5 is mediated by the importin beta subunit. J Biol Chem 275:23462-23470, 2000
12. Schedlich LJ, Young TF, Firth SM, et al.: Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 273:18347-18352, 1998
13. Butt AJ, Firth SM, King MA, et al.: Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem 275:39174-39181, 2000
14. Gill ZP, Perks CM, Newcomb PV, et al.: Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J Biol Chem 272:25602-25607, 1997
15. Hong J, Zhang G, Dong F, et al.: Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 277:10489-10497, 2002
16. Lee HY, Chun KH, Liu B, et al.: Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Res 62:3530-3537, 2002
17. Kirman I, Cekic V, Poltaratskaia N, et al.: Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: Lower insulin-like growth factor binding protein 3 levels may, in part, account for this change. Surgery 132:186-192, 2002
18. Langholz E, Munkholm P, Nielsen OH, et al.: Incidence and prevalence of ulcerative colitis in Copenhagen County from 1962 to 1987. Scand J Gastroenterol 26:1247-1256, 1991
19. Munkholm P, Langholz E, Nielsen OH, et al.: Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-1987: a sixfold increase in incidence. Scand J Gastroenterol 27:609-614, 1992
20. Tvede M, Bondesen S, Nielsen OH, et al.: Serum antibodies to Bacteroides species in chronic inflammatory bowel disease. Scand J Gastroenterol 18:403-409, 1983
21. Modric T, Silha JV, Shi Z, et al.: Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 142:1958-1967, 2001
22. Toth M, Chvyrkova I, Bernardo MM, et al.: Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochem Biophys Res Commun 308:386-395, 2003
23. Greenstein AJ: Cancer in inflammatory bowel disease. Mt Sinai J Med 67:227-240, 2000
24. Ma J, Pollak MN, Giovannucci E, et al.: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625, 1999